Status:
COMPLETED
A Clinical Trial of a Gamified Attention Bias Modification Training in Anxious Youth
Lead Sponsor:
National Institutes of Health Clinical Center (CC)
Conditions:
Anxiety Disorders
Eligibility:
All Genders
8-17 years
Phase:
NA
Brief Summary
Background: Attention bias modification training (ABMT) and cognitive behavioral therapy (CBT) likely target different aspects of aberrant threat responses in anxiety disorders and may be combined to ...
Detailed Description
Background: Attention bias modification training (ABMT) and cognitive behavioral therapy (CBT) likely target different aspects of aberrant threat responses in anxiety disorders and may be combined to ...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- ALL JUVENILE SUBJECTS WITH AN ANXIETY DISORDER:
- Diagnosis: Current Diagnosis of Social Phobia, Separation Anxiety, Generalized Anxiety Disorder, or Panic Disorder (Based on K-SADS (juveniles))
- Symptom Severity: Clinically significant, ongoing anxiety symptoms
- Clinical Impairment: Clinically significant, ongoing distress or impairment from anxiety
- Age: 8 - 17 (subjects who consent as 17- year-olds but turn 18 during the course of the study will be eligible to complete all procedures completed by other subjects who consent as 17- year- old but do not turn 18).
- Consent: can give consent/assent (Parents will provide consent; minors will provide assent)
- IQ: all subjects will have intelligence quotient (IQ) \> 70 (Assessment relies on WASI)
- Language: all subjects will speak English
- EXCLUSION CRITERIA:
- Any serious medical condition or condition that interferes with participation
- Pregnancy
- Current use of any psychoactive substance; current suicidal ideation; current diagnosis of attention deficit hyperactivity disorder (ADHD) of sufficient severity to require pharmacotherapy.
- Current diagnoses Tourette's Disorder, obsessive compulsive disorder (OCD), post-traumatic distress disorder, conduct disorder
- Past or current history of mania, psychosis, or severe pervasive developmental disorder
- Recent use of an selective serotonin reuptake inhibitor (SSRI); all subjects must have been free of any SSRI-use for at least one month (fluoxetine six months) and must not have been treated with an SSRI for their current depressive episode.
- National Institute of Mental Health (NIMH) employees and staff and their immediate family members will be excluded from the study per NIMH policy
Exclusion
Key Trial Info
Start Date :
November 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2023
Estimated Enrollment :
121 Patients enrolled
Trial Details
Trial ID
NCT03283930
Start Date
November 1 2016
End Date
September 1 2023
Last Update
April 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NIH Clinical Center
Bethesda, Maryland, United States, 20892